Molecular Correlates of Soy in Humans
Molecular Correlates of Soy in Humans
批准号:
6666953
负责人:
Raymond C. Bergan
金额:
$37.13万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-30 至 2005-08-31
关键词:
biological signal transduction biomarker cell cycle proteins cell proliferation chemoprevention clinical research clinical trial phase II enzyme inhibitors focal adhesion kinase gene expression genistein human subject human therapy evaluation male neoplasm /cancer genetics neoplasm /cancer nutrition therapy neoplastic process nutrition aspect of cancer nutrition related tag patient oriented research phosphorylation polymerase chain reaction prostate neoplasms protein tyrosine kinase soybeans vascular cell adhesion molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Soy is a promising cancer chemopreventive agent. Soy consumers appear to have a lower incidence of metastatic prostate cancer (PCa). We have shown that a soy constituent, genistein, a tyrosine kinase inhibitor, acts to antagonize metastatic behavior by increasing PCa cell adhesion, while at high concentrations it inhibits PCa cell growth. We recently completed a single dose phase I study in humans, demonstrating that genistein modulates intracellular tyrosine phosphorylation (or cell signaling) of blood cells. To further understand soy's in vivo effects, we are implementing a phase II clinical trial in which patients with PCa who are to have radical prostatectomy will be randomized to treatment (or not) with 2 mg genistein/kg/day, allowing evaluation of tissue for intermediate biomarkers. We hypothesize that treatment with soy-derived genistein will antagonize metastatic behavior of human prostate cells, will have long term effects on cell signaling, and will also effect prostate cell survival and growth. We propose the following specific aims: #1 : Determine whether soy antagonizes metastatic behavior in humans. Metastatic prostate cells can be detected by amplifying PSA specific RNA by reverse transcriptase polymerase chain reaction (RT/PCR). We will measure soy's ability to decrease circulating metastatic prostate cells in peripheral blood, as well as in operative field blood. In addition, treatment-related effects upon cellular morphology (a surrogate measure of effect upon cell adhesion) will be measured by quantitative image analysis of prostate tissue. #2: Evaluate effects of soy upon cell signaling pathways in vivo. Comparing soy-treated and control prostate tissue, changes in gene expression will be measured in adhesion-related genes (FAK and endoglin), as well as by gene array-based gene profiling. In addition, long-term effects upon cell signaling in vivo will be sought by measuring changes in protein-tyrosine phosphorylation of blood cells over time. #3: Determine whether soy modulates prostate cell survival and growth in vivo. Investigations will examine soy's effects upon a panel of biomarkers related to prostate cell viability and growth, including apoptotic index, cell-associated PCNA, p27 expression, serum PSA and serum testosterone.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preventing invasive prostate cancer
-
批准号:10566591
-
项目类别:
-
资助金额:$53.58万
-
财政年份:2023
-
负责人:Raymond C. Bergan
-
依托单位:
Therapeutically targeting cancer cell motility
-
批准号:9206893
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Raymond C. Bergan
-
依托单位:
Career Development Program
-
批准号:8932481
-
项目类别:
-
资助金额:$8.51万
-
财政年份:2015
-
负责人:Raymond C. Bergan
-
依托单位:
P-4: Modulation of Prostate CA Cell Motility by Chemopreventive Agt Genistein
-
批准号:8055507
-
项目类别:
-
资助金额:$19.86万
-
财政年份:2010
-
负责人:Raymond C. Bergan
-
依托单位:
Modulation of Prostate Cancer Cell Motility by Chemopreventive Agent Genistein
-
批准号:7587126
-
项目类别:
-
资助金额:$21.5万
-
财政年份:2008
-
负责人:Raymond C. Bergan
-
依托单位:
Genistein-mediated Regulation of Prostate Cancer Cell Motility
-
批准号:7524345
-
项目类别:
-
资助金额:$32.12万
-
财政年份:2008
-
负责人:Raymond C. Bergan
-
依托单位:
Genistein-mediated Regulation of Prostate Cancer Cell Motility
-
批准号:8113270
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2008
-
负责人:Raymond C. Bergan
-
依托单位:
Genistein-mediated Regulation of Prostate Cancer Cell Motility
-
批准号:8301022
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2008
-
负责人:Raymond C. Bergan
-
依托单位:
Genistein-mediated Regulation of Prostate Cancer Cell Motility
-
批准号:7901440
-
项目类别:
-
资助金额:$31.39万
-
财政年份:2008
-
负责人:Raymond C. Bergan
-
依托单位:
Genistein-mediated Regulation of Prostate Cancer Cell Motility
-
批准号:7690913
-
项目类别:
-
资助金额:$31.94万
-
财政年份:2008
-
负责人:Raymond C. Bergan
-
依托单位:
PHASE 1 AND PHASE 2 CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
-
批准号:7543350
-
项目类别:
-
资助金额:$160.2万
-
财政年份:2003
-
负责人:Raymond C. Bergan
-
依托单位:--
Molecular Correlates of Soy in Humans
-
批准号:6584698
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2002
-
负责人:Raymond C. Bergan
-
依托单位:
PHASE I MULTIPLE DOSE STUDY OF OLTIPRAZ IN SMOKERS - WOR
-
批准号:6157694
-
项目类别:
-
资助金额:$42.23万
-
财政年份:1999
-
负责人:Raymond C. Bergan
-
依托单位:
PHASE I MULTIPLE DOSE STUDY OF OLTIPRAZ IN SMOKERS - WOR
-
批准号:6346993
-
项目类别:
-
资助金额:$79.53万
-
财政年份:1999
-
负责人:Raymond C. Bergan
-
依托单位:
Translational Oncology
-
批准号:10205362
-
项目类别:
-
资助金额:$0.47万
-
财政年份:1997
-
负责人:Raymond C. Bergan
-
依托单位:
PHASE 1 AND PHASE 2 CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS -261035157
-
批准号:6994829
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Raymond C. Bergan
-
依托单位:
PHASE 1 AND PHASE 2 CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS-261035157
-
批准号:7191432
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Raymond C. Bergan
-
依托单位:
Career Development Program
-
批准号:9128690
-
项目类别:
-
资助金额:$8.19万
-
财政年份:--
-
负责人:Raymond C. Bergan
-
依托单位:
P-4: Modulation of Prostate CA Cell Motility by Chemopreventive Agt Genistein
-
批准号:8375659
-
项目类别:
-
资助金额:$14.8万
-
财政年份:--
-
负责人:Raymond C. Bergan
-
依托单位:
P-4: Modulation of Prostate CA Cell Motility by Chemopreventive Agt Genistein
-
批准号:8241165
-
项目类别:
-
资助金额:$20.11万
-
财政年份:--
-
负责人:Raymond C. Bergan
-
依托单位:
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
-
批准号:61602201
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:周雄辉
-
依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
-
批准号:81170309
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:颜桥
-
依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
-
批准号:30672394
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2006
-
负责人:陆豪杰
-
依托单位: